A clinical trial to test a promising new multiple sclerosis therapeutic gets underway in Christchurch later this month.
The therapeutic, developed by Auckland biopharmaceutical company Innate Therapeutics, also has the potential to fight certain cancers and infectious diseases.
The trial will test MIS416, a naturally occurring agent derived from bacteria, in people with progressive multiple sclerosis (MS). The trial has begun recruiting patients and will be conducted at the Primorus Clinical Trials purpose-built unit in Christchurch. ... Read More -
http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1397